Fuel Gas System Market worth $1,837.7 million by 2031 | MarketsandMarkets™

MarketsandMarkets projects the global fuel gas system market for combined-cycle power plants will grow from USD 1,410.2 million in 2026 to USD 1,837.7 million by 2031, a 5.4% CAGR. North America is forecast to be the fastest-growing region, while Asia Pacific is expected to hold the largest share; plants above 600 MW are projected to grow at a 5.9% CAGR. The report cites CCGT investment, data-center power demand, gas infrastructure, and hydrogen-natural gas blending as factors supporting demand.

Analysis

The investable signal is much weaker than the growth narrative suggests: this is a vendor-sponsored market forecast for a fragmented equipment niche, not evidence of awarded projects or incremental orders. Even if CCGT construction accelerates, fuel-gas packages are purchased only as projects advance through financing, permitting and final investment decisions; pipeline capacity, interconnection and turbine delivery can defer or cancel that demand. Near term, the report itself is unlikely to move EMR. Its potential benefit is indirect—automation, measurement and control content around new generation—and the AspenTech deal is too broad to treat as proof of fuel-gas revenue leverage. Over 1–3 months, watch CCGT project awards and EMR orders/guidance for energy and process automation rather than the market-size estimate. Over 6–18 months, large plants and variable gas quality could increase package complexity and supplier value per project, but hydrogen-blend demand remains contingent on turbine qualification, operating economics and gas-network compatibility. The contrarian risk: data-center power demand may translate into grid upgrades, demand response or other generation before it translates into gas-plant orders; pipeline and permitting bottlenecks are potential brakes. The thesis weakens if announced CCGT projects fail to reach FID, gas-generation additions slow, or EMR does not show corresponding order strength. No company-specific valuation or earnings bridge is supplied, so the report does not justify a directional EMR position on its own.

Key Decisions for Investors

• Do not trade EMR on this report alone; treat it as low-confidence thematic evidence, not an earnings catalyst.
• Set a 1–3 month watchlist for CCGT FIDs, turbine awards and pipeline/interconnection approvals, alongside EMR order commentary. Upgrade the thesis only if project conversion and company-level orders confirm it.
• For a 6–18 month screen, compare EMR with more directly exposed gas-turbine and power-equipment suppliers, including GE Vernova and Siemens Energy; verify order exposure and valuation before taking relative positions.
• Keep hydrogen-blend fuel-system revenue as optionality, not a base case, until turbine certification, actual operating projects and repeat orders demonstrate commercial adoption.